Key Highlights
- Casey Orvin appointed Chief Commercial Officer at Alcanza Clinical Research
- Leads business development, feasibility, marketing, and public relations functions
- Former CCO at CenExel and President of the Society for Clinical Research Sites
- Aims to enhance patient diversity and inclusion in clinical trials
- Experienced in growing large clinical research site networks
Source: PR Newswire
Notable Quotes
- “Casey’s leadership capabilities and extensive industry relationships will enable Alcanza to achieve its growth-filled vision.” — Carlos Orantes, CEO at Alcanza Clinical Research
- “Sponsors and CROs are looking for a new kind of site partner who can bring innovative recruitment and engagement solutions to the table.” — Casey Orvin, Chief Commercial Officer at Alcanza Clinical Research
SoHC's Take
The appointment of Casey Orvin as Chief Commercial Officer at Alcanza Clinical Research marks a significant strategic move for the organization. With his robust background in operational and commercial leadership within the clinical research industry, Casey brings a wealth of experience that is expected to drive Alcanza’s mission forward. His previous roles at CenExel and the Society for Clinical Research Sites highlight his capability to lead large, complex networks and initiatives aimed at increasing diversity and sustainability in clinical trials.
Under Casey’s leadership, Alcanza is well-positioned to enhance its business development, feasibility, marketing, and public relations functions, ensuring that the company not only grows but also reaches a more inclusive and representative patient population. This move aligns with the broader industry trend towards enhancing diversity and inclusion in clinical trials, a critical factor for the future of medical research and development.
